Notice2024-17131
Statement of Organization, Functions, and Delegations of Authority
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 5, 2024
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Abstract
SAMHSA has modified its organizational structure.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 150 (Monday, August 5, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 150 (Monday, August 5, 2024)]
[Notices]
[Pages 63437-63438]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-17131]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Substance Abuse and Mental Health Services Administration
(SAMHSA).
ACTION: Organization, functions, and delegations of authority.
-----------------------------------------------------------------------
SUMMARY: SAMHSA has modified its organizational structure.
SUPPLEMENTARY INFORMATION: Part M of the Substance Abuse and Mental
Health Services Administration (SAMHSA) Statement of Organization,
Functions, and Delegations of Authority for the Department of Health
and Human Services at 71 FR 19740-19741, April 17, 2006, is amended to
reflect changes of the functional statements for the Center for
Substance Abuse Treatment (CSAT). This amendment reflects the addition
of one new division and two branches. CSAT has taken the lead in
addressing the substance use disorder (SUD) treatment needs of
Americans, focusing primarily on opioid treatment, developing a crisis
continuum, improving adult and adolescent substance use treatment, and
increasing access to and the quality of SUD treatment and recovery
services. CSAT is dedicated to collaborating with grantees and
stakeholders to enhance the accessibility of innovative services and
evidence-based treatment modalities through grants and technical
assistance.
In order to enhance administrative and operational efficiencies,
CSAT proposes that each supervisor within the center should have a
staff to supervisor ratio of 1 supervisor to 10 staff person or less.
There is currently a twelve to one staff to supervisor ratio in the
Division of Services Improvement (DSI)--with one branch having 17
staff. Managing 10 or more employees can be challenging for a first-
line supervisor, who must effectively handle employee management and
oversee grants and contracts. By adding the Division of Health Systems
Improvement (DHSI) and two branches, Integrated Care Branch (ICB) and
Opioid Treatment Branch (OTB) the staff to supervisor ratio would
decrease to eight to one. Moreover, streamlined and smaller divisions/
branches, with specific focus areas, will provide additional oversight
and management by the second-level supervisor for these important
Federal grants and contracts.
Center for Substance Abuse Treatment
Division of Health Systems Improvement
The proposed DHSI will focus on equity, medications for opioid use
disorder (MOUD), and the continuum of care consistent with and
necessary for the achievement of goals outlined in the President's
Unity Agenda and the Office of National Drug Control Policy's National
Drug Control Strategy. Refining the alignment of grant portfolios by
the scope and span of grants and function, subject matter areas, age
group focus (adolescents versus adults), and geographic focus
(community versus state) will allow for improved efficiencies and
service. The two branches in DHSI will be ICB and OTB. The new division
will allow for dedicated leadership focusing on opioid treatment,
developing a crisis continuum, improving adult and adolescent substance
use treatment, and increasing access to and the quality of SUD
treatment and recovery services. The proposed new division and two new
branches are better aligned based on content and goal; the major grant
programs impacted by this change are described below.
ICB will primairly focus on increasing access to and improving the
quality of services of comprehensive, coordinated, patient-centered
care across the continuum. The branch will manage the Minority AIDS
Initiative (MAI) and Screening, Brief Intervention, and Referral to
Treatment (SBIRT) programs both of which are authorized under the
Public Health Service Act (PHSA), title V, section 509. MAI seeks to
increase engagement in care for racial and ethnic underrepresented
individuals with SUD and/or co-occurring substance use and mental
disorders (COD) who are at risk for or living with HIV/AIDS and receive
HIV/AIDS services/treatment. SBIRT is a comprehensive, integrated,
public health approach to the delivery of early intervention and
treatment services for persons with substance use disorders, as well as
those who are at risk of developing these disorders.
<bullet> OTB will primarily focus on providing evidence-based
[[Page 63438]]
comprehensive care to individuals with opioid use disorder (OUD),
reduce harm, and effectively address the opioid crisis through service
grants primarily to community-based organizations. This includes
service grants that support the provision of MOUD such as methadone,
buprenorphine and naltrexone which allow patients to receive treatment
while maintaining their daily responsibilities and lives. Work in this
branch will include engaging in community outreach and education
efforts to raise awareness about the opioid epidemic, prevention
strategies, and available treatment options. This is different from the
work done in our state-based funding programs (State Opioid Response
and Substance Use Prevention, Treatment, and Recovery Services Block
Grants) which are housed in the Division of State and Community Systems
(DSCS) and separate from the focus of the Division of Pharmacologic
Therapies (DPT) which works with Opioid Treatment Programs to provide
regulatory and provider support and does not fund opioid treatment.
There is no overlap in the work of the existing divisions, DSCS and
DPT, and the proposed OTB within the proposed DHSI. The OTB will manage
the Medication-Assisted Treatment--Prescription Drug and Opioid
Addiction (MAT-PDOA) and Targeted Capacity Expansion: Special Projects
(TCE-SP) programs, both of which are authorized under section 509 of
the PHSA, as amended. The purpose of MAT-PDOA is to provide resources
to help expand and enhance access to MOUD. It is expected that this
program will help to (1) increase access to MOUD for individuals with
OUD, including individuals from diverse racial, ethnic, sexual and
gender minority communities; and (2) decrease illicit opioid use and
prescription opioid misuse. The purpose of TCE-SP is to implement
targeted strategies for the provision of SUD or COD harm reduction,
treatment, and/or recovery support services to support an under-
resourced population or unmet need identified by the community.
Delegations of Authority
All delegations and redelegations of authority to officers and
employees of SAMHSA which were in effect immediately prior to the
effective date of this reorganization shall continue to be in effect.
Authority: 44 U.S.C. 3101.
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2024-17131 Filed 8-2-24; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on August 5, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.